Day CP - Search Results

1

Fluorescent protein-assisted purification for gene expression profiling.

Zaidi MR, Day CP, Merlino G. Zaidi MR, et al. Among authors: day cp. Methods Mol Biol. 2011;699:393-405. doi: 10.1007/978-1-61737-950-5_19. Methods Mol Biol. 2011. PMID: 21116994

2

From UVs to metastases: modeling melanoma initiation and progression in the mouse.

Zaidi MR, Day CP, Merlino G. Zaidi MR, et al. Among authors: day cp. J Invest Dermatol. 2008 Oct;128(10):2381-91. doi: 10.1038/jid.2008.177. J Invest Dermatol. 2008. PMID: 18787547 Free article. Review.

3

Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Day CP, Carter J, Bonomi C, Esposito D, Crise B, Ortiz-Conde B, Hollingshead M, Merlino G. Day CP, et al. Pigment Cell Melanoma Res. 2009 Jun;22(3):283-95. doi: 10.1111/j.1755-148X.2009.00545.x. Epub 2009 Jan 19. Pigment Cell Melanoma Res. 2009. PMID: 19175523 Free PMC article.

4

Illuminating progression: tracking melanoma metastasis in a gene therapy setting.

Day CP, Merlino G. Day CP, et al. Pigment Cell Melanoma Res. 2011 Apr;24(2):260-1. doi: 10.1111/j.1755-148X.2011.00826.x. Pigment Cell Melanoma Res. 2011. PMID: 21226857 No abstract available.

5

Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin.

Day CP, Carter J, Bonomi C, Hollingshead M, Merlino G. Day CP, et al. Int J Cancer. 2012 Jan 1;130(1):190-9. doi: 10.1002/ijc.25978. Epub 2011 Apr 20. Int J Cancer. 2012. PMID: 21312195 Free PMC article.

6

Meeting report: The future of preclinical mouse models in melanoma treatment is now.

Merlino G, Flaherty K, Acquavella N, Day CP, Aplin A, Holmen S, Topalian S, Van Dyke T, Herlyn M. Merlino G, et al. Among authors: day cp. Pigment Cell Melanoma Res. 2013 Jul;26(4):E8-E14. doi: 10.1111/pcmr.12099. Epub 2013 Apr 8. Pigment Cell Melanoma Res. 2013. PMID: 23531109 Free PMC article. No abstract available.

7

"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts.

Day CP, Carter J, Weaver Ohler Z, Bonomi C, El Meskini R, Martin P, Graff-Cherry C, Feigenbaum L, Tüting T, Van Dyke T, Hollingshead M, Merlino G. Day CP, et al. PLoS One. 2014 Nov 4;9(11):e109956. doi: 10.1371/journal.pone.0109956. eCollection 2014. PLoS One. 2014. PMID: 25369133 Free PMC article.

8

Preclinical mouse cancer models: a maze of opportunities and challenges.

Day CP, Merlino G, Van Dyke T. Day CP, et al. Cell. 2015 Sep 24;163(1):39-53. doi: 10.1016/j.cell.2015.08.068. Cell. 2015. PMID: 26406370 Free PMC article. Review.

9

Concepts in Cancer Modeling: A Brief History.

Thomas RM, Van Dyke T, Merlino G, Day CP. Thomas RM, et al. Among authors: day cp. Cancer Res. 2016 Oct 15;76(20):5921-5925. doi: 10.1158/0008-5472.CAN-16-1293. Epub 2016 Sep 30. Cancer Res. 2016. PMID: 27694601 Free PMC article. Review.

10

Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.

Day CP, Marchalik R, Merlino G, Michael H. Day CP, et al. Lab Invest. 2017 Jun;97(6):698-705. doi: 10.1038/labinvest.2016.155. Epub 2017 Jan 16. Lab Invest. 2017. PMID: 28092363 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters